RUNX2 and neoplasm: Subsequent transcriptomic and epigenomic data integration has allowed us to reveal subtype‐specific molecular pathways governed by AP‐1, SMAD3 and RUNX1/RUNX2 transcription factors (TF) in both pd‐GBSCs and bulk tumours.